Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Related Citations for PubMed (Select 19366986)

1.

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

Sharma MD, Hou DY, Liu Y, Koni PA, Metz R, Chandler P, Mellor AL, He Y, Munn DH.

Blood. 2009 Jun 11;113(24):6102-11. doi: 10.1182/blood-2008-12-195354. Epub 2009 Apr 14.

2.

Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase.

Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, Azuma M, Blazar BR, Mellor AL, Munn DH.

J Clin Invest. 2007 Sep;117(9):2570-82.

3.

IDO activates regulatory T cells and blocks their conversion into Th17-like T cells.

Baban B, Chandler PR, Sharma MD, Pihkala J, Koni PA, Munn DH, Mellor AL.

J Immunol. 2009 Aug 15;183(4):2475-83. doi: 10.4049/jimmunol.0900986. Epub 2009 Jul 27.

4.

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.

Munn DH, Sharma MD, Hou D, Baban B, Lee JR, Antonia SJ, Messina JL, Chandler P, Koni PA, Mellor AL.

J Clin Invest. 2004 Jul;114(2):280-90. Erratum in: J Clin Invest. 2004 Aug;114(4):599.

5.

Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

Sharma MD, Hou DY, Baban B, Koni PA, He Y, Chandler PR, Blazar BR, Mellor AL, Munn DH.

Immunity. 2010 Dec 14;33(6):942-54. doi: 10.1016/j.immuni.2010.11.022. Epub 2010 Dec 9.

6.

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, Mellor AL.

Immunity. 2005 May;22(5):633-42.

7.

Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.

Ou X, Cai S, Liu P, Zeng J, He Y, Wu X, Du J.

J Cancer Res Clin Oncol. 2008 May;134(5):525-33. Epub 2007 Oct 2.

PMID:
17909857
8.

IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.

Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Rostami A, Xu H.

J Immunol. 2010 Nov 15;185(10):5953-61. doi: 10.4049/jimmunol.1001628. Epub 2010 Oct 13.

9.

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA 3rd, Kahler DJ, Pihkala J, Soler AP, Munn DH, Prendergast GC, Mellor AL.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17073-8. doi: 10.1073/pnas.0806173105. Epub 2008 Oct 24.

10.

p-Coumaric acid inhibits indoleamine 2, 3-dioxygenase expression in murine dendritic cells.

Kim SI, Jeong YI, Jung ID, Lee JS, Lee CM, Yoon MS, Seong EY, Kim JI, Lee JD, Park YM.

Int Immunopharmacol. 2007 Jun;7(6):805-15. Epub 2007 Feb 27.

PMID:
17466914
11.

Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.

Favre D, Mold J, Hunt PW, Kanwar B, Loke P, Seu L, Barbour JD, Lowe MM, Jayawardene A, Aweeka F, Huang Y, Douek DC, Brenchley JM, Martin JN, Hecht FM, Deeks SG, McCune JM.

Sci Transl Med. 2010 May 19;2(32):32ra36. doi: 10.1126/scitranslmed.3000632.

12.

Indoleamine 2,3-dioxygenase, Tregs and cancer.

Munn DH.

Curr Med Chem. 2011;18(15):2240-6. doi: 0929-8673/11 $58.00+.00.

PMID:
21517755
13.

1-MT enhances potency of tumor cell lysate-pulsed dendritic cells against pancreatic adenocarcinoma by downregulating the percentage of Tregs.

Li Y, Xu J, Zou H, Wang C.

J Huazhong Univ Sci Technolog Med Sci. 2010 Jun;30(3):344-8. doi: 10.1007/s11596-010-0354-3. Epub 2010 Jun 17.

PMID:
20556579
14.

Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.

Zeng M, Guinet E, Nouri-Shirazi M.

Transpl Immunol. 2009 Dec;22(1-2):82-92. doi: 10.1016/j.trim.2009.07.004. Epub 2009 Jul 25.

PMID:
19635560
15.

Physiologic control of IDO competence in splenic dendritic cells.

Baban B, Chandler PR, Johnson BA 3rd, Huang L, Li M, Sharpe ML, Francisco LM, Sharpe AH, Blazar BR, Munn DH, Mellor AL.

J Immunol. 2011 Sep 1;187(5):2329-35. doi: 10.4049/jimmunol.1100276. Epub 2011 Aug 3.

16.

Neem leaf glycoprotein overcomes indoleamine 2,3 dioxygenase mediated tolerance in dendritic cells by attenuating hyperactive regulatory T cells in cervical cancer stage IIIB patients.

Roy S, Barik S, Banerjee S, Bhuniya A, Pal S, Basu P, Biswas J, Goswami S, Chakraborty T, Bose A, Baral R.

Hum Immunol. 2013 Aug;74(8):1015-23. doi: 10.1016/j.humimm.2013.04.022. Epub 2013 Apr 27.

PMID:
23628394
17.

Modulation of regulatory T cell-Th17 balance by plasmacytoid dendritic cells.

Gautreau L, Chabannes D, Heslan M, Josien R.

J Leukoc Biol. 2011 Sep;90(3):521-7. doi: 10.1189/jlb.0810455. Epub 2011 Jun 7.

18.

Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice.

Misaki K, Morinobu A, Saegusa J, Kasagi S, Fujita M, Miyamoto Y, Matsuki F, Kumagai S.

Arthritis Res Ther. 2011 May 18;13(3):R77. doi: 10.1186/ar3339.

19.

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.

Speeckaert R, Vermaelen K, van Geel N, Autier P, Lambert J, Haspeslagh M, van Gele M, Thielemans K, Neyns B, Roche N, Verbeke N, Deron P, Speeckaert M, Brochez L.

Eur J Cancer. 2012 Sep;48(13):2004-11. doi: 10.1016/j.ejca.2011.09.007. Epub 2011 Oct 25.

PMID:
22033321
20.

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.

Sun J, Yu J, Li H, Yang L, Wei F, Yu W, Liu J, Ren X.

J Exp Clin Cancer Res. 2011 Sep 14;30:82. doi: 10.1186/1756-9966-30-82.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk